What is CVE-2026-12647?
A Missing Authorization vulnerability in Ivanti Neurons for ITSM before 2026.2 allows a remote authenticated attacker to execute arbitrary code on the server.
The record classifies CVE-2026-12647 under weakness class CWE-862. Its CVSS v3 base vector states that the flaw is reachable remotely over the network, needs low-privilege credentials, needs no user interaction, and has high impact on confidentiality, integrity, availability. 1 affected-product entry is recorded, across 1 vendor, listed below. The identifier was first published 44 days ago.
Severity and exploitation probability
- CVSS v3.1 base score
- 9.9 — CRITICAL
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H - EPSS (FIRST)
- 1.2% probability of exploitation in the next 30 days, higher than 68.2% of all scored CVEs
- CISA KEV
- Not listed in the CISA Known Exploited Vulnerabilities catalog
- Threadlinqs priority
- 7.7/10 — a Threadlinqs composite of the CVSS base score, the EPSS percentile and public exploit availability
- Published
- 2026-09-08, last modified 2026-09-09
Is CVE-2026-12647 being exploited?
It currently carries a trending score of 44 in the Threadlinqs vulnerability feed.
Affected products and versions
- Ivanti: Neurons for ITSM
How to fix CVE-2026-12647
No vendor patch reference has been recorded for CVE-2026-12647 in the tracked sources. Follow the references below for a fix, and treat the products listed above as exposed until the vendor states otherwise.
Threat activity tracking CVE-2026-12647
1 tracked threat in the Threadlinqs corpus references CVE-2026-12647, either in the campaign’s CVE list or as an indicator on the campaign record.
Sources
Enriched from CVE.org, FIRST EPSS, GitHub Security Advisories. Last verified by Threadlinqs on .